US FDA Inconsistency? Leucovorin’s Magnitude Of Effect Rewarded, Idebenone Needs New Trial

 
• By Bridget Silverman
  
The US FDA's approval decisions are upending expectations in rare disease drug development. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Complete Response Letters

More from Rare Diseases